Inositol pyrophosphates determine exocytotic capacity

Details Inositol pyrophosphates determine exocytotic capacity Inositol pyrophosphates determine exocytotic capacity

2008-08-27

2010-12-21

Bertoglio, Valarie (Department: 1632)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S325000, C435S375000

Reexamination Certificate

active

07855049

ABSTRACT:
The invention provides reagents and methods for treating type II diabetes, as well as methods for identifying compounds for treating type II diabetes.

REFERENCES:
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: WO 90/11092 (1990-10-01), None
patent: WO 03/066087 (2003-08-01), None
patent: WO 2004/006838 (2004-01-01), None
Zambre et al. (1999), “Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5.” Biochem. Pharmacol. 57: 1159-1164.
Zhang et al. (1996), “Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression.” Cancer Gene Therapy 3: 31-38.
Barker et al. (2002), “Phosphorylated inositol compounds in beta -cell stimulus-response coupling.” Am. J. Physiol. Endocrinol. Metab. 283: E1113-22.
Barker et al. (2004), “Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle.” Biochem. J. 380: 465-73.
Belldegrun et al. (1993), “Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene (s): implications for live cancer vaccines.” J. Natl. Cancer Inst. 85: 207-16.
Bennett et al. (2006), “Inositol pyrophosphates: metabolism and signaling.” Cell Mol. Life Sci. 63: 552-64.
Berridge (1995), “Inositol trisphosphate and calcium signaling.” Ann. N. Y. Acad. Sci. 766: 31-43.
Cejvan et al. (2003), “Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats.” Diabetes 52: 1176-1181.
Efanov et al. (1997), “Inositol hexakisphosphate stimulates non-Ca2+-mediated and primes Ca2+-mediated exocytosis of insulin by activation of protein kinase C.” Proc. Natl. Acad. Sci. USA 94: 4435-9.
Fagan et al. (1998), “Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse.” Surgery 124:254-8.
Fawell et al. (1994), “Tat-mediated delivery of heterologous proteins into cells.” Proc. Natl. Acad. Sci. USA 91(2): 664-8.
Ferrantini et al. (1993), “Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.” Cancer Research 53: 1107-1112.
Ferrantini et al. (1994), “IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.” J. Immunology 153: 4604-4615.
Frankel et al. (1988), “Cellular uptake of the tat protein from human immunodeficiency virus.” Cell 55(6): 1189-93.
Gillis et al. (1996), “Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules.” Neuron 16: 1209-20.
Green et al. (1988), “Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.” Cell 55(6): 1179-88.
Ho et al. (2001), “Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.” Cancer Res. 61(2): 474-7.
Høy et al. (2002), “Inositol hexakisphosphate promotes dynamin I- mediated endocytosis.” Proc. Natl. Acad. Sci. USA 99: 6773-7.
Høy et al. (2003), “Involvement of protein kinase C-epsilon in inositol hexakisphosphate-induced exocytosis in mouse pancreatic beta-cells.” J. Biol. Chem. 278: 35168-71.
Illies et al. (2007), “Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells.” Science 318(5854): 1299-302.
International Search Report for WO 09/027107, mailed on Dec. 29, 2008.
Irvine et al. (2001), “Back in the water: the return of the inositol phosphates.” Nat. Rev. Mol. Cell Biol. 2: 327-38.
J.T. Lexicon Knockout Mouse NIH-0750, Mouse Genome Database (MGD), Mouse Genome Informatics Web Site, informatics.jax.org/external/ko/lexicon/1223.html (Jul. 18, 2006).
Kaido et al. (1995), “IFN-alpha 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice.” Int. J. Cancer 60: 221-229.
Kamimura et al. (2004), “The IHPK1 gene is disrupted at the 3p21.31 breakpoint of t(3;9) in a family with type 2 diabetes mellitus.” J. Hum. Genet. 49: 360-5.
Larsson et al. (1997), “Inhibition of phosphatases and increased Ca2+ channel activity by inositol hexakisphosphate.” Science 278: 471-4.
Lee et al. (2007), “Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates.” Science 316: 109-12.
Leibiger et al. (1998), “Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways.” Mol. Cell. 1(6): 933-938.
Lilja et al. (2004), “Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis.” J. Biol. Chem. 279: 29534-41.
Luo et al. (2001), “GRAB: a physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase.” Neuron 31: 439-51.
Marchetti et al. (2006), “The pancreatic beta-cell in human Type 2 diabetes.” Nutr. Metab. Cardiovasc. Dis. 16 Suppl 1: S3-6.
Merglen et al. (2004), “Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells.” Endocrinology 145: 667-78.
Nagamatsu et al. (2007), “IP7 debut in insulin release.” Science 318(5854): 1249-50.
Nagata et al. (2005), “Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death.” J. Biol. Chem. 280: 1634-40.
Ogura et al. (1990), “Implantation of genetically manipulated fibroblasts into mice as antitumor alpha-interferon therapy.” Cancer Research 50: 5102-5106.
Olofsson et al. (2002), “Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells.” Pflugers Archiv. 444: 43-51.
Pesesse et al. (2004), “Signaling by higher inositol polyphosphates. Synthesis of bisdiphosphoinositol tetrakisphosphate (“InsP8”) is selectively activated by hyperosmotic stress.” J. Biol. Chem. 279: 43378-81.
Ray (2007), “InsP7 and insulin release.” Sci. STKE 2007(414): tw435.
Reddy et al. (1997), “Synthesis of 2- and 5-diphospho-myo-inositol pentakisphosphate (2- and 5-PP-InsP5), intracellular mediators” Tetrahedron Letters 38: 4951-2.
Rorsman et al. (2003), “Insulin granule dynamics in pancreatic beta cells.” Diabetologia 46: 1029-45.
Saiardi et al. (1999), “Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases.” Curr. Biol. 9: 1323-6.
Saiardi et al. (2001), “Identification and characterization of a novel inositol hexakisphosphate kinase.” J. Biol. Chem. 276(42): 39179-85.
Saiardi et al. (2004), “Phosphorylation of proteins by inositol pyrophosphates.” Science 306: 2101-5.
Santodonato et al. (1996), “Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.” Human Gene Therapy 7: 1-10.
Santodonato et al. (1997), “Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.” Gene Therapy 4: 1246-1255.
Schwarze et al. (1999), “In vivo protein transduction:

Affiliated with

Also associated with

Rating

Inositol pyrophosphates determine exocytotic capacity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inositol pyrophosphates determine exocytotic capacity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inositol pyrophosphates determine exocytotic capacity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4163339